science
plus
.abes.fr
|
explorer
À propos de :
Sabin C
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
Sabin C
Sabin Caroline A.
Sabin Caroline
Sabin C.
Sabin C. A.
Sabin Caroline A
Sabin Caroline A.
personal mailbox
c.sabin@pcps.ucl.ac.uk
familyName
Sabin
Given name
C.
Caroline
C. A.
C
Caroline A.
Caroline A
Caroline A.
is
relates
of
http://hub.abes.fr/oup/periodical/cid/2009/volume_48/issue_9/101086598502/authorship/4
http://hub.abes.fr/oup/periodical/jid/2000/volume_182/issue_6/101086317636/authorship/3
http://hub.abes.fr/oup/periodical/jid/2009/volume_200/issue_5/101086605024/authorship/2
http://hub.abes.fr/oup/periodical/jid/1998/volume_177/issue_1/101086513806/authorship/4
http://hub.abes.fr/oup/periodical/jid/2004/volume_190/issue_10/101086425075/authorship/2
http://hub.abes.fr/oup/periodical/jid/2002/volume_186/issue_8/101086343801/authorship/7
http://hub.abes.fr/oup/periodical/ageing/1999/volume_28/issue_5/101093ageing285433/authorship/2
http://hub.abes.fr/oup/periodical/aje/1993/volume_138/issue_10/101093oxfordjournalsajea116789/authorship/2
http://hub.abes.fr/oup/periodical/jac/2010/volume_65/issue_1/101093jacdkp408/authorship/4
http://hub.abes.fr/oup/periodical/jid/1997/volume_175/issue_4/101086513970/authorship/2
http://hub.abes.fr/oup/periodical/jid/1999/volume_179/issue_1/101086314563/authorship/5
http://hub.abes.fr/oup/periodical/jid/2000/volume_181/issue_5/101086315476/authorship/1
http://hub.abes.fr/oup/periodical/jid/2004/volume_189/issue_8/101086383040/authorship/11
http://hub.abes.fr/oup/periodical/jid/1997/volume_176/issue_2/101086517288/authorship/1
http://hub.abes.fr/oup/periodical/jid/1999/volume_180/issue_3/101086314936/authorship/2
http://hub.abes.fr/oup/periodical/jac/2001/volume_47/issue_4/101093jac474371/authorship/1
http://hub.abes.fr/oup/periodical/jac/2008/volume_61/issue_3/101093jacdkm522/authorship/6
http://hub.abes.fr/oup/periodical/jid/2005/volume_192/issue_8/101086466534/authorship/12
http://hub.abes.fr/oup/periodical/cid/2004/volume_38/issue_supplement2/101086381448/authorship/1
http://hub.abes.fr/oup/periodical/jid/1999/volume_180/issue_2/101086314890/authorship/3
http://hub.abes.fr/oup/periodical/jid/2000/volume_181/issue_5/101086315444/authorship/4
http://hub.abes.fr/oup/periodical/jid/2002/volume_186/issue_4/101086341777/authorship/2
http://hub.abes.fr/oup/periodical/jid/1998/volume_178/issue_4/101086515676/authorship/1
http://hub.abes.fr/oup/periodical/jid/2008/volume_197/issue_8/101086533454/authorship/3
http://hub.abes.fr/oup/periodical/jid/2000/volume_181/issue_3/101086315301/authorship/2
http://hub.abes.fr/oup/periodical/jid/2002/volume_186/issue_supplement1/101086342965/authorship/2
http://hub.abes.fr/oup/periodical/jid/2006/volume_193/issue_8/101086501472/authorship/7
http://hub.abes.fr/oup/periodical/jid/2010/volume_201/issue_3/101086649897/authorship/2
http://hub.abes.fr/oup/periodical/jid/2001/volume_183/issue_10/101086320191/authorship/3
http://hub.abes.fr/oup/periodical/jid/1997/volume_176/issue_6/101086514145/authorship/2
http://hub.abes.fr/oup/periodical/jid/2001/volume_184/issue_4/101086322045/authorship/1
http://hub.abes.fr/oup/periodical/jid/1999/volume_180/issue_3/101086314926/authorship/2
http://hub.abes.fr/oup/periodical/jid/2009/volume_200/issue_1/101086599314/authorship/1
http://hub.abes.fr/oup/periodical/jid/2008/volume_197/issue_11/101086587843/authorship/6
http://hub.abes.fr/oup/periodical/jid/1997/volume_175/issue_1/101093infdis1751164/authorship/1
http://hub.abes.fr/oup/periodical/jac/2007/volume_59/issue_5/101093jacdkm067/authorship/2
http://hub.abes.fr/oup/periodical/jid/2004/volume_189/issue_6/101086381783/authorship/3
is
Contributor
of
Sexual Transmission of Hepatitis C in MSM May Not Be Confined to Those with HIV Infection
is
Author
of
What is the risk of mortality following diagnosis of multidrug-resistant HIV-1?
Effect of HIV-1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy
Human Serum Amyloid P Component Protects against Escherichia coli O157:H7 Shiga Toxin 2 In Vivo: Therapeutic Implications for Hemolytic-Uremic Syndrome
Factors Influencing Increases in CD4 Cell Counts of HIV-Positive Persons Receiving Long-Term Highly Active Antiretroviral Therapy
Human Herpesvirus 8: Seroepidemiology among Women and Detection in the Genital Tract of Seropositive Women
The Association between Hepatitis C Virus Genotype and Human Immunodeficiency Virus Disease Progression in a Cohort of Hemophilic Men
Human Immunodeficiency Virus Rebound after Suppression to <400 Copies/mL during Initial Highly Active Antiretroviral Therapy Regimens, according to Prior Nucleoside Experience and Duration of Suppression
CD4 Lymphocyte Count as a Predictor of the Duration of Highly Active Antiretroviral Therapy—Induced Suppression of Human Immunodeficiency Virus Load
The Prognostic Value of a Single Hepatitis C Virus RNA Load Measurement Taken Early after Human Immunodeficiency Virus Seroconversion
The Relationships between Ethnicity, Sex, Risk Group, and Virus Load in Human Immunodeficiency Virus Type 1 Antiretroviral-Naive Patients
Valacyclovir Provides Optimum Acyclovir Exposure for Prevention of Cytomegalovirus and Related Outcomes after Organ Transplantation
Is There a General Tendency for CD4 Lymphocyte Decline to Speed Up during Human Immunodeficiency Virus Infection? Evidence from the Italian Seroconversion Study
A Randomized, Controlled Trial Comparing Ganciclovir to Ganciclovir Plus Foscarnet (Each at Half Dose) for Preemptive Therapy of Cytomegalovirus Infection in Transplant Recipients
Reply
Quantitative Effects of Valacyclovir on the Replication of Cytomegalovirus (CMV) in Persons with Advanced Human Immunodeficiency Virus Disease: Baseline CMV Load Dictates Time to Disease and Survival
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
The Effect of Valaciclovir on Cytomegalovirus Viremia and Viruria Detected by Polymerase Chain Reaction in Patients with Advanced Human Immunodeficiency Virus Disease
Relationships among the Detection of p24 Antigen, Human Immunodeficiency Virus (HIV) RNA Level, CD4 Cell Count, and Disease Progression in HIV-Infected Individuals with Hemophilia
Lipid Profiles in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?
Emergence of the H208Y mutation in the reverse transcriptase (RT) of HIV-1 in association with nucleoside RT inhibitor therapy
Pitfalls of Assessing Hepatotoxicity in Trials and Observational Cohorts
Treatment comparisons in HIV infection: the benefits and limitations of observational cohort studies
Observing the process of care: a stroke unit, elderly care unit and general medical ward compared.
Reduction in Human Immunodeficiency Virus Type 1 Mutations Associated with Drug Resistance after Initiating New Therapeutic Regimens in Pretreated Patients
Cytomegalovirus Seropositivity and Human Immunodeficiency Virus Type 1 RNA Levels in Individuals with Hemophilia
Resistance Profiles in Patients with Viral Rebound on Potent Antiretroviral Therapy
Factors influencing lopinavir and atazanavir plasma concentration
Acquired Immunodeficiency Syndrome (AIDS) Risk in Recent and Long-standing Human Immunodeficiency Virus Type 1 (HIV-1)-infected Patients with Similar CD4 Lymphocyte Counts
HIV Viremia and the Development of AIDS-Related Lymphoma in Patients Treated with Highly Active Antiretroviral Therapy
Changes in Lymphocyte Subsets in Human Immunodeficiency Virus—Positive Persons with <5 CD4 T Lymphocytes/mm3
Serologic Evidence of Human Herpesvirus 8 Transmission by Homosexual but Not Heterosexual Sex
Interrelationships among Quantity of Human Cytomegalovirus (HCMV) DNA in Blood, Donor-Recipient Serostatus, and Administration of Methylprednisolone as Risk Factors for HCMV Disease following Liver Transplantation
Relationship between IgM Antibody to Human Cytomegalovirus, Virus Load, Donor and Recipient Serostatus, and Administration of Methylprednisolone as Risk Factors for Cytomegalovirus Disease after Liver Transplantation
The Rate of Viral Rebound after Attainment of an HIV Load <50 Copies/mL According to Specific Antiretroviral Drugs in Use: Results from a Multicenter Cohort Study
Impact of HIV on Host-Virus Interactions during Early Hepatitis C Virus Infection
Virological Response to Initial Antiretroviral Regimens Containing Abacavir or Tenofovir
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
